Mark Germain - Net Worth and Insider Trading

Mark Germain Net Worth

The estimated net worth of Mark Germain is at least $36,938 dollars as of 2024-05-05. Mark Germain is the Director of Pluri Inc and owns about 6,424 shares of Pluri Inc (PLUR) stock worth over $36,938. Details can be seen in Mark Germain's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark Germain has not made any transactions after 2018-03-16 and currently still holds the listed stock(s).

Transaction Summary of Mark Germain

Mark Germain Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Germain owns 4 companies in total, including Pluri Inc (PLUR) , ChromaDex Corp (CDXC) , and Reis Inc (REIS) among others .

Click here to see the complete history of Mark Germain’s form 4 insider trades.

Insider Ownership Summary of Mark Germain

Ticker	Comapny	Transaction Date	Type of Owner
PLUR	Pluri Inc	2018-03-16	director
CDXC	ChromaDex Corp	2009-05-13	director
REIS	Reis Inc	2008-02-28	director
		2023-01-01	director & other: Chairman

Mark Germain Latest Holdings Summary

Mark Germain currently owns a total of 1 stock. Mark Germain owns 6,424 shares of Pluri Inc (PLUR) as of March 16, 2018, with a value of $36,938.

Latest Holdings of Mark Germain

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PLUR	Pluri Inc	2018-03-16	6,424	5.75	36,938

Holding Weightings of Mark Germain

Mark Germain Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Germain has made a total of 0 transactions in Pluri Inc (PLUR) over the past 5 years. The most-recent trade in Pluri Inc is the sale of 573 shares on March 16, 2018, which brought Mark Germain around $67,892.

Insider Trading History of Mark Germain

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Germain Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Germain Ownership Network

Ownership Network List of Mark Germain

No Data

Ownership Network Relation of Mark Germain

Mark Germain Owned Company Details

What does Pluri Inc do?

Who are the key executives at Pluri Inc?

Mark Germain is the director of Pluri Inc. Other key executives at Pluri Inc include Chief Executive Officer Zami Aberman , 10 percent owner Clover Wolf Capital - Limited Partnership , and Chief Financial Officer Yaky Yanay .

Pluri Inc (PLUR) Insider Trades Summary

Over the past 18 months, Mark Germain made no insider transaction in Pluri Inc (PLUR). Other recent insider transactions involving Pluri Inc (PLUR) include a net sale of 2,000 shares made by Zami Aberman ,

In summary, during the past 3 months, insiders sold 0 shares of Pluri Inc (PLUR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 250 shares of Pluri Inc (PLUR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 250 shares.

Pluri Inc (PLUR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pluri Inc Insider Transactions

No Available Data

What does ChromaDex Corp do?

Who are the key executives at ChromaDex Corp?

Mark Germain is the director of ChromaDex Corp. Other key executives at ChromaDex Corp include SVP Finance / Interim CFO Brianna Gerber , 10 percent owner Champion River Ventures Ltd , and director & 10 percent owner & Chief Executive Officer Jaksch Frank L Jr .

ChromaDex Corp (CDXC) Insider Trades Summary

Over the past 18 months, Mark Germain made no insider transaction in ChromaDex Corp (CDXC). Other recent insider transactions involving ChromaDex Corp (CDXC) include a net purchase of 3,467,778 shares made by Champion River Ventures Ltd , a net purchase of 7,000 shares made by Robert N Fried , and a net purchase of 7,000 shares made by Steven D Rubin .

In summary, during the past 3 months, insiders sold 0 shares of ChromaDex Corp (CDXC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChromaDex Corp (CDXC) were sold and 3,493,778 shares were bought by its insiders, resulting in a net purchase of 3,493,778 shares.

ChromaDex Corp (CDXC)'s detailed insider trading history can be found in Insider Trading Tracker table.

ChromaDex Corp Insider Transactions

No Available Data

What does Reis Inc do?

Who are the key executives at Reis Inc?

Mark Germain is the director of Reis Inc. Other key executives at Reis Inc include Vice Chairman James J Burns , 10 percent owner Michael J Leffell , and 10 percent owner Kempner Partners Davidson .

Reis Inc (REIS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Reis Inc (REIS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reis Inc (REIS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Reis Inc (REIS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reis Inc Insider Transactions

No Available Data

What does Scinai Immunotherapeutics Ltd do?

Who are the key executives at Scinai Immunotherapeutics Ltd?

Mark Germain is the director & other: Chairman of Scinai Immunotherapeutics Ltd. Other key executives at Scinai Immunotherapeutics Ltd include Chief Financial Officer Uri Ben-or , Chief Scientist Tamar Ben-yedidia , and director & Chief Executive Officer Amir Reichman .

Scinai Immunotherapeutics Ltd (SCNI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Scinai Immunotherapeutics Ltd (SCNI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Scinai Immunotherapeutics Ltd (SCNI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Scinai Immunotherapeutics Ltd (SCNI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Scinai Immunotherapeutics Ltd Insider Transactions

No Available Data

Mark Germain Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Germain. You might contact Mark Germain via mailing address: Wellsford Real Properties Inc, 535 Madison Avenue, New York Ny 10022.

Discussions on Mark Germain

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.